Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 October 2022 | Story Anthony Mthembu | Photo Kaleidoscope
Tobias van den Bergh
Tobias van den Bergh, President of the Southern African Association for Counselling and Development in Higher Education (SAACHDE)

Tobias van den Bergh, Counselling Psychologist at the University of the Free State, has been appointed as the President of the Southern African Association for Counselling and Development in Higher Education (SAACDHE).  The appointment became official at the annual SAACDHE conference, which took place in Pretoria from 12 to 14 September 2022. As such, van den Bergh perceives this appointment as an opportunity: “To be part of a creative process that tackles the challenges faced in higher education and knowing the difficulty that students and my colleagues across the country are struggling with, accepting this appointment felt right.”

The role of SAACDHE

“The organisation represents members of several higher education counselling and career development centres from the SADC region. The organisation’s mission is to promote, guide, and advance best practices in centres at institutions of higher education,” explained Van den Bergh. Through this representation and assistance, members are able to provide quality support to the students they serve. SAACDHE members include mental health professionals, social workers, HIV/AIDS counsellors, researchers, and career development specialists from more than 15 higher education institutions in South Africa and Botswana. Furthermore, Van den Bergh asserts that, “SAACDHE represents its members through lobbying for increased institutional support, the promotion of scholarly, ethical, and best practices, and the training and development of professionals.”

Van den Bergh as President of the organisation

 As the newly elected President of the organisation, there are several challenges that Van den Bergh believes require the immediate attention of SAACDHE.  For instance, he maintains that student populations and the mental health challenges they face have grown at a substantial rate over the past few decades. However, the staff capacity in counselling and career development centres has not increased commensurately. As such, the challenge in this regard is that the need for mental health interventions continues to grow, but the capacity is not sufficient to deal with those challenges and to fill the gap in public mental health services. To address this challenge, he indicates that “the organisation is striving to innovate counselling centres, and to find ways to work smarter and be preventative where possible”.

In addition, Van den Bergh is adamant about ensuring that the organisation continues to be innovative in the way mental health services are provided to students, and to create practices that are culturally and contextually relevant. However, his long-term vision for the organisation is, “to continue serving as a training, development, and practice-based organisation, so that we can equip members with support and knowledge that will help them to continue helping students in a smarter and better way”.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept